Holen Sie sich die Stockscreener-App
13.05
2.92%
0.37
Handel nachbörslich:
12.79
-0.26
-1.99%
Schlusskurs vom Vortag:
$12.68
Offen:
$12.54
24-Stunden-Volumen:
31,318
Relative Volume:
1.11
Marktkapitalisierung:
$26.71M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-4.85M
KGV:
-42.10
EPS:
-0.31
Netto-Cashflow:
$-3.95M
1W Leistung:
+19.29%
1M Leistung:
+15.59%
6M Leistung:
-34.16%
1J Leistung:
+95.55%
1-Tages-Spanne:
$12.40
$13.20
1-Wochen-Bereich:
$10.55
$13.20
52-Wochen-Spanne:
$5.70
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Firmenname
Cadrenal Therapeutics Inc
Sektor
Branche
Telefon
904-300-0701
Adresse
822 A1A NORTH, PONTE VEDRA
Vergleichen Sie CVKD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
13.05 | 25.95M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
389.88 | 100.71B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.87 | 58.84B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.91 | 61.52B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
661.32 | 40.01B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
319.32 | 38.20B | 3.81B | -644.79M | -669.77M | -6.24 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-18 | Eingeleitet | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Aktie (CVKD) Neueste Nachrichten
RF.PRE Added to High Probability Setup ListJuly 2025 Spike Watch & Reliable Breakout Stock Forecasts - Newser
Best data tools to analyze Cadrenal Therapeutics Inc. stockTrade Performance Summary & Consistent Profit Focused Trading Strategies - Newser
Using data tools to time your Cadrenal Therapeutics Inc. exitPortfolio Return Report & Weekly Breakout Stock Alerts - Newser
Trend analysis for Cadrenal Therapeutics Inc. this weekMarket Performance Recap & Weekly Return Optimization Alerts - Newser
Using economic indicators to assess Cadrenal Therapeutics Inc. potentialJuly 2025 Analyst Calls & Safe Entry Point Alerts - Newser
Live Scanner Shows Breakout on Cadrenal Therapeutics Inc.2025 Technical Overview & AI Forecast for Swing Trade Picks - sundaytimes.kr
Can machine learning forecast Cadrenal Therapeutics Inc. recoveryJuly 2025 Breakouts & Daily Volume Surge Signals - Newser
Is Skyline Builders Group Holding Limited stock reversal real or fakeInsider Selling & Weekly High Return Stock Opportunities - Newser
Using data models to predict Cadrenal Therapeutics Inc. stock movementJuly 2025 Market Mood & Advanced Technical Analysis Signals - Newser
Is it time to cut losses on Relmada Therapeutics Inc.Long Setup & Real-Time Stock Entry Alerts - Newser
How sentiment analysis helps forecast RPIDWall Street Watch & Low Risk Entry Point Guides - Newser
Investors Hope for Bounce in Cadrenal Therapeutics Inc. After SelloffMarket Sentiment Report & AI Powered Trade Plan Recommendations - newsyoung.net
Earnings visualization tools for Cadrenal Therapeutics Inc.Earnings Recap Summary & Entry Point Confirmation Signals - Newser
Combining price and volume data for Cadrenal Therapeutics Inc.2025 Analyst Calls & Real-Time Chart Breakout Alerts - Newser
Custom strategy builders for tracking Cadrenal Therapeutics Inc.Market Risk Analysis & Growth Focused Stock Reports - Newser
Real time breakdown of Cadrenal Therapeutics Inc. stock performanceGap Down & Weekly Setup with High ROI Potential - Newser
Is Cadrenal Therapeutics Inc. stock a good pick for beginnersPortfolio Growth Summary & Free Accurate Trade Setup Notifications - newsyoung.net
Q3 EPS Estimate for Cadrenal Therapeutics Lifted by Analyst - Defense World
How TOYO stock performs during market volatility2025 Fundamental Recap & Verified Momentum Stock Alerts - thegnnews.com
Is It Too Late to Sell Cadrenal Therapeutics Inc.Stock Surge & Weekly High Return Stock Forecasts - classian.co.kr
Cadrenal Therapeutics Advances Tecarfarin Development - TipRanks
Q1 Earnings Forecast for CVKD Issued By Noble Financial - Defense World
Signal strength of CLSD stock in tech scannersFree Pattern Breakout Entry Stock Forecast - Newser
Will LILAK face regulatory challengesHigh ROE Investment Ideas - sisain.net
Tools to monitor Cadrenal Therapeutics Inc. recovery probabilityFast Movement Forecast for Trading Success - Newser
Cadrenal Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - BioSpace
How to forecast ABIG trends using time seriesFree Low Volatility Stable Growth Picks - Newser
Visual analytics tools that track Cadrenal Therapeutics Inc. performanceWeekly Market Direction and Sector Summary - Newser
CVKD Files 8-K; Exhibit 99.1 Contains Q2 2025 Financials - Stock Titan
Cadrenal Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Cadrenal Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Order flow analysis tools used on Cadrenal Therapeutics Inc.Daily Trade Setup Forecast with Confidence - Newser
Analyzing net buyer seller activity in Cadrenal Therapeutics Inc.Free AI-Powered Trade Planning with Indicators - Newser
TZUP Stock Chart Analysis: Bullish or Bearish Pattern FormingTrade Plan With Low Risk High Return - Newser
Is ECDA a Top Dividend Stock to Watch in 2025Pattern Breakout Tracker with Screener Tools - Newser
Main Inc. stock performs during market volatilityDaily Technical Forecast for Quick Gains - Newser
Cadrenal Therapeutics Inc. stock outlook for YEARChart Driven Entry Timing for Swing Trades - Newser
How volatile is SBXD.WS stock10-Bagger Stock Radar - mustnews.co.kr
How Cadrenal Therapeutics Inc. stock performs during market volatilityInvestment Timeline and ROI Summary Report - Newser
Real time pattern detection on CVLT stockExit Strategy Guide With Risk Control Plan - Newser
Can CDIOW hit a new high this monthTechnical Setup Guide for Daily Watchlist - Newser
How to interpret RSI for GCT Semiconductor Holding Inc. stockSummary of Trade Cycles in 5-Year Range - Newser
Is RITM.PRD a candidate for recovery playWeekly Breakout Forecast with Entry Zones - Newser
Finanzdaten der Cadrenal Therapeutics Inc-Aktie (CVKD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):